marketing

Novartis dissolves agreement to market Pear Therapeutics’ prescription digital therapeutics for substance/ opioid abuse

by

_______________

As San­doz returns mar­ket­ing rights for dig­i­tal ther­a­peu­tics to Pear, what does it mean for co-pro­mote arrange­ments? (MM&M):

“San­doz, the gener­ics divi­sion of Novar­tis, is alter­ing com­mer­cial course, return­ing mar­ket­ing duties for two pre­scrip­tion dig­i­tal ther­a­peu­tics (DTx) back to Pear Ther­a­peu­tics. The move, which some had antic­i­pat­ed, comes 18 months after the two signed a co-pro­mo­tion deal.

Since the Sandoz/Pear pact was wide­ly seen as a lit­mus test of sorts for pharma’s role in help­ing dis­trib­ute this nascent tech­nol­o­gy, the com­mer­cial break-up rais­es ques­tions about the via­bil­i­ty of such part­ner­ships going for­ward. It also high­lights the par­ties’ some­times con­flict­ing pri­or­i­ties: [Read more…] about Novar­tis dis­solves agree­ment to mar­ket Pear Ther­a­peu­tics’ pre­scrip­tion dig­i­tal ther­a­peu­tics for substance/ opi­oid abuse

Neuroimaging as a marketing tool: Key Neurotech Patent #2

by

– Illus­tra­tive image from U.S. Patent No. 6,099,319

As men­tioned, we are fea­tur­ing a foun­da­tion­al Per­va­sive Neu­rotech patent a day, from old­er to new­er by issue date. Today we are shar­ing a 2000 patent assigned to The Nielsen Company.

U.S. Patent No. 6,099,319: Neu­roimag­ing as a mar­ket­ing tool

  • Assignee(s): The Nielsen Company
  • Inventor(s): Ger­ald Zalt­man, Stephen M. Kosslyn
  • Tech­nol­o­gy Cat­e­go­ry: Hybrid
  • Issue Date: August 8, 2000

SharpBrains’ Take:

The ‘319 patent is one of Nielsen’s sev­er­al patents that relate to ana­lyz­ing brain data in response to a wide vari­ety of stim­uli for pur­pos­es of eval­u­at­ing the stim­uli, such as dis­cern­ing emo­tion­al respons­es to sen­so­ry inputs. [Read more…] about Neu­roimag­ing as a mar­ket­ing tool: Key Neu­rotech Patent #2

Brain training franchisor LearningRx settles FTC complaint about its marketing claims

by

BrainTraining_learningRxLearn­ingRx To Pay $200K For Alleged­ly Unproven Claims That Brain Train­ing Can Improve Income, Treat Autism & ADHD (Con­sumerist):

“The com­pa­ny behind the Learn­ingRX “brain train­ing” pro­gram has agreed to pay a $200,000 set­tle­ment and to stop mak­ing claims that its sys­tem is clin­i­cal­ly proven to treat seri­ous health con­di­tions, or that it can [Read more…] about Brain train­ing fran­chisor Learn­ingRx set­tles FTC com­plaint about its mar­ket­ing claims

How leading marketing pros train their brains, stay ahead of the curve

by

brain_circuitsThe Brainy Insight for B2B (Rene­gade Media):

“We all know Chief Mar­ket­ing Offi­cers (CMOs) are extra­or­di­nar­i­ly busy peo­ple. They’re jug­gling strate­gic, tac­ti­cal, man­age­r­i­al, ven­dor and cus­tomer chal­lenges, all while try­ing to stay ahead of the curve. This is where [Read more…] about How lead­ing mar­ket­ing pros train their brains, stay ahead of the curve